Inovio Pharma (INO.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Nov12

Inovio Pharmaceuticals Set to Raise About $26.5 Million Through Public Offering of 13.158 Million Shares

12:17

Nov11

Inovio Pharma released FY2025 Q3 earnings on November 10 After-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.8721 (forecast USD -0.4233)

00:00

Inovio Pharma released FY2025 9 Months Earnings on November 10 After-Market EST, Actual Revenue: USD 65.34K, Actual EPS: USD -1.1157

00:00

Nov3

INOVIO Completes Rolling Submission for INO-3107 Biologics License Application

13:06

Inovio Pharma to Release FY2025 Q3 Earnings on November 10 After-Market EST, Forecast EPS -0.4233 USD

00:16

Sep25

INOVIO to Present INO-3107 Data and Next-Generation DNA Drug Technologies at Upcoming Scientific Conferences

12:06

Schedules & Filings

Schedules

Filings

Nov10

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -45.5 M, EPS -0.8721

Aug12

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -23.52 M, EPS -0.6057

May13

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 65.34 K, Net Income -19.69 M, EPS -0.51

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More